Post edited 12:20 pm – December 15, 2009 by RevGenetics
Folks…
Just an FYI:
A Notice of Allowance has been granted for Geron's patent, here in the USA.
Since I just found out about this today and the patent has yet to be issued, I need to reassess Astral Fruit for my customers because of this news, as I never thought a product of nature would be able to be patented. Specially considering different formulations of astragalus has been used for years in various herbal meds, that could have easily (as a consequence) had this function of astragalus benefit the consumer. A new discovery for the effects of a astragalus extracts do not, in my opinion, constitute sufficient novelty for it's natural extracts to be patented. We have a unique formulation of our own as well that we believe falls clearly outside of the patent claims granted, however we must still consider what this patent means for nutraceuticals in general.
Dr. B, this sort of patent really bothers me, as it can likely mean other natural ingredients can be patented by big pharma. This is different than creating a new seed, molecule, or organism. This is patenting pre-existing natural products of nature.
In the meantime, excuse me while I go buy some Geron stock (and maybe you should too) while thinking about the future of Astral Fruit… It's possible we may consider a license from Geron to continue selling Astral Fruit, or simply discontinue selling this version of Astral Fruit altogether.
There is another material that is available after all, that we can consider.
As soon as Geron has an actual patent issued, we will stop selling Cycloastragenol to acknowledge the patent provided to Geron. We will then consider the future of Astral Fruit as a licensed product or as a product that uses different ingredients, that are still available.
For now… we will have a fire sale until we run out of product.
Cheers
A